NVO

Q: What is the price of Novo Nordisk (NVO) today?

The price of Novo Nordisk (NVO) today is R$ 300,50, with a variation of -57.97% compared to the last year. The price of Novo Nordisk (NVO) started the year trading around R$ 467,09 and today it is at R$ 300,50. Follow the real-time price chart, the historical price of Novo Nordisk (NVO), and stock data from Ibovespa and international markets.

Q: When does Novo Nordisk (NVO) pay dividends?

Novo Nordisk (NVO) distributed dividends in the last year,in the months of April e August totaling R$ 6,39. The Dividend Yield for the last 12 months is 2,83%.

Q: Novo Nordisk (NVO) is it worth it?

Currently, Novo Nordisk (NVO) is priced at R$ 300,50, with a P/E of 15,51%, representing a deviation of 29,44% from its historical average P/E. In the last year, the stock showed a variation of -57.97% in its price and distributed R$ 6,39 in dividends, resulting in a Dividend Yield of 2,83%. The total shareholder return was -57,97%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy shares of Novo Nordisk (NVO)?

Investing in shares of Novo Nordisk (NVO) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 shares of Novo Nordisk (NVO) yield today?

The yield of Novo Nordisk (NVO) was -21,95% in the last month, -57,97% in the last year and 82,21% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of R$ 9,14 in dividends, um Dividend Yield de 2,83%.If you wanted to buy 100 shares of Novo Nordisk (NVO) today, the total investment would be based on the current price of R$ 300,50.If past performance were to repeat, the return on your investment would be:In 1 year: R$ 12.629,86In 5 years: R$ 54.753,41In 10 years: 72.410,57It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Novo Nordisk A/S

Price

US$ 55,34

variation (12m)

-57,97%

p/l

15,51

p/vp

9,75

DIVIDEND YIELD

2,83%

quote NVO

BVMF

NVO

If you had invested

year ago

6 months

1 year

5 years

10 years

today you would have

today you would have:

*The figure considers the reinvestment of dividends.

profitability of NVO

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

-21,95%

3 months

-18,42%

1 year

-57,97%

2 years

-38,51%

5 years

82,21%

10 years

140,97%

real profitability

profitability minus inflation.

1 month

-21,95%

3 months

-18,83%

1 year

-60,07%

2 years

-43,95%

5 years

33,14%

10 years

42,86%

Indicators NVO

check out the fundamentals of Novo Nordisk shares

P/L

15,51

Sector: -3,27 Industry: -3,27

P/SALES (PSR)

5,53

Sector: -3,71 Industry: -3,71

P/VP

9,75

Sector: 1,74 Industry: 1,74

DIVIDEND YIELD (DY)

2,83%

Sector: - Industry: -

ROA

21,91%

Sector: -63,89% Industry: -63,89%

ROE

62,86%

Sector: -67,90% Industry: -67,90%

ROIC

21,73%

Sector: -2.087,71% Industry: -2.087,71%

Net Margin

35,63%

Sector: -43,60% Industry: -43,60%

GROSS MARGIN

83,93%

Sector: 40,50% Industry: 40,50%

OPERATING MARGIN

45,78%

Sector: -43,47% Industry: -43,47%

P/EBITDA

10,61

Sector: -3,14 Industry: -3,14

P/EBIT

11,38

Sector: -3,42 Industry: -3,42

P/ASSETS

3,40

Sector: 1,29 Industry: 1,29

VPA

5,84

Sector: 1,78 Industry: 1,78

LPA

3,67

Sector: -2,10 Industry: -2,10

EQUITY / ASSETS

0,35

Sector: 0,41 Industry: 0,41

CAGR REVENUES 5 YEARS

18,55%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

20,65%

Sector: - Industry: -

FAIR PRICE OF Novo Nordisk ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 55,34

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-60,32%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

NVO indicators history

DRAG THE FRAME TO SEE MORE DATA

comparator of Stocks

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	Net Margin
JNJ	19,04	5,50	28,88%	2,80%	US$ 431,37 B	25,00%
PFE	13,45	1,62	12,08%	6,68%	US$ 144,63 B	16,84%
ABBV	79,66	228,58	286,94%	3,38%	US$ 334,19 B	7,31%
MRK	13,05	4,36	33,44%	3,75%	US$ 214,13 B	25,79%
BMY	19,31	5,58	28,87%	5,13%	US$ 97,52 B	10,58%
GILD	22,64	7,29	32,21%	2,72%	US$ 142,89 B	21,87%
AZN	30,26	5,60	18,51%	1,91%	US$ 251,01 B	14,68%
ZTS	26,68	14,00	52,48%	1,19%	US$ 69,70 B	27,83%
HALO	15,59	26,12	167,47%	0,00%	US$ 8,69 B	47,28%
REGN	13,88	2,07	14,89%	0,30%	US$ 61,90 B	31,37%
AMGN	23,87	21,27	89,11%	3,15%	US$ 158,02 B	18,96%
VRTX	27,92	5,91	21,18%	0,00%	US$ 101,55 B	31,86%
ADMA	20,53	10,77	52,45%	0,00%	US$ 4,29 B	44,06%
MCK	27,24	-99,86	-366,63%	0,41%	US$ 86,18 B	0,84%
BIIB	13,38	1,16	8,68%	0,00%	US$ 20,48 B	15,31%
CAH	22,58	-13,38	-59,26%	1,37%	US$ 35,25 B	0,70%
HRMY	11,93	2,79	23,40%	0,00%	US$ 2,16 B	23,42%

comparison of NVO with indexes

If you had invested (change) 2 years a year ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

dividend history NVO dividend history

Current DY: 2,83%

5-year average DY: 1,39%

DRAG THE FRAME TO SEE MORE DATA

type	date with	payment date	value
Dividends	18/08/2025	26/08/2025	0,58480000
Dividends	31/03/2025	08/04/2025	1,09920000
Dividends	16/08/2024	26/08/2024	0,51260000
Dividends	25/03/2024	02/04/2024	0,66380000
Dividends	21/08/2023	29/08/2023	0,44180000
Dividends	27/03/2023	04/04/2023	0,59435000
Dividends	15/08/2022	23/08/2022	0,29180000
Dividends	28/03/2022	05/04/2022	0,37065000
Dividends	17/08/2021	25/08/2021	0,27855000
Dividends	29/03/2021	07/04/2021	0,47470000
Dividends	17/08/2020	25/08/2020	0,25890000
Dividends	30/03/2020	07/04/2020	0,39130000
Dividends	19/08/2019	27/08/2019	0,22470000
Dividends	25/03/2019	02/04/2019	0,38850000
Dividends	20/08/2018	28/08/2018	0,16375000
Dividends	26/03/2018	03/04/2018	0,28920000
Dividends	21/08/2017	29/08/2017	0,16795000
Dividends	27/03/2017	04/04/2017	0,23970000
Dividends	15/08/2016	23/08/2016	0,16550000
Dividends	22/03/2016	30/03/2016	0,34970000
Dividends	23/03/2015	31/03/2015	0,26645000
Dividends	25/03/2014	02/04/2014	0,30305000
Dividends	25/03/2013	02/04/2013	0,22643000
Dividends	26/03/2012	03/04/2012	0,18319000
Dividends	28/03/2011	05/04/2011	0,13579000
Dividends	29/03/2010	07/04/2010	0,09786000
Dividends	23/03/2009	31/03/2009	0,07816000
Dividends	17/03/2008	25/03/2008	0,06785000
Dividends	12/03/2007	20/03/2007	0,06195000
Dividends	13/03/2006	21/03/2006	0,03459000
Dividends	14/03/2005	22/03/2005	0,03086000
Dividends	19/03/2004	29/03/2004	0,02605000
Dividends	28/03/2003	07/04/2003	0,01882500
Dividends	15/03/2002	25/03/2002	0,01424000
Dividends	23/03/2001	02/04/2001	0,01580000
Dividends	28/03/2000	06/04/2000	0,01245000
Dividends	29/03/1999	06/04/1999	0,01115000
Dividends	31/03/1998	08/04/1998	0,00610000
Dividends	29/04/1997	07/05/1997	0,00570000
Dividends	03/05/1996	14/05/1996	0,00425000
Dividends	28/04/1995	16/05/1995	0,00385000
Dividends	02/05/1994	18/05/1994	0,00265000
Dividends	28/04/1993	13/05/1993	0,00280000
Dividends	04/05/1992	20/05/1992	0,00270000
Dividends	25/04/1991	10/05/1991	0,00300000
Dividends	27/04/1990	15/05/1990	0,00310000

ABOUT THE COMPANY Novo Nordisk

Novo Nordisk A/S

Average user rating I10

5.0 (215 people)

Estados Unidos

94 years

Foundation: 1931

1981

Year of debut on the stock exchange - 44 years

45.000

Employees

Additional Information

The Company Novo Nordisk A/S (Estados Unidos), is listed on NYSE with a market value of $ 253,39 Billions, having a net worth of $ 25,98 Billions.

With a total of 45.000 employees, the company is listed in the sector of Cuidados de saúde and categorized in industry of Biotecnologia.

In the last 12 months the Company had a revenue of $ 45,85 Billions, which generated a profit in the amount of $ 16,33 Billions.

As for its main indicators, the Company has a P/E ratio of 15,51, a P/B ratio of 9,75 and in the last 12 months the dividend yield of NVO was at 2,83%.

The Company is traded in Brazil through the BDR N1VO34, or can be purchased on abroad through the ticker NVO.

Market value

US$ 253,39 Billions

Net worth

US$ 25,98 Billions

US$ 25.984.230.000,00

Assets

US$ 74,54 Billions

US$ 74.544.370.000,00

Total Number of Shares

4,45 Billions

4.447.000.000

Average Daily Trading Volume

US$ 16,71 Milhões

US$ 16.712.686,00

Sector

Cuidados de saúde

Industry

Biotecnologia

NVO

NVO revenue and profits

NVO results

DRAG THE FRAME TO SEE MORE DATA

NVO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 680,52 25,01% (12M)

P/L

27,24

0,41%

ROE

-366,63%

P/VP

-99,86

CAH - Cardinal Health

US$ 147,49 37,15% (12M)

P/L

22,58

1,37%

ROE

-59,26%

P/VP

-13,38

JNJ - Johnson & Johnson

US$ 176,49 11,52% (12M)

P/L

19,04

2,80%

ROE

28,88%

P/VP

5,50

MRK - Merck & Co.

US$ 84,99 --23,70% (12M)

P/L

13,05

3,75%

ROE

33,44%

P/VP

4,36

PFE - Pfizer

US$ 24,92 --5,92% (12M)

P/L

13,45

6,68%

ROE

12,08%

P/VP

1,62

AZN - AstraZeneca

US$ 80,05 --5,03% (12M)

P/L

30,26

1,91%

ROE

18,51%

P/VP

5,60

ABBV - AbbVie

US$ 208,36 9,31% (12M)

P/L

79,66

3,38%

ROE

286,94%

P/VP

228,58

BFRA - Biofrontera

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 680,52 25,01% (12 M)

P/L

27,24

0,41%

ROE

-366,63%

P/VP

-99,86

CAH - Cardinal Health

US$ 147,49 37,15% (12 M)

P/L

22,58

1,37%

ROE

-59,26%

P/VP

-13,38

JNJ - Johnson & Johnson

US$ 176,49 11,52% (12 M)

P/L

19,04

2,80%

ROE

28,88%

P/VP

5,50

MRK - Merck & Co.

US$ 84,99 --23,70% (12 M)

P/L

13,05

3,75%

ROE

33,44%

P/VP

4,36

PFE - Pfizer

US$ 24,92 --5,92% (12 M)

P/L

13,45

6,68%

ROE

12,08%

P/VP

1,62

AZN - AstraZeneca

US$ 80,05 --5,03% (12 M)

P/L

30,26

1,91%

ROE

18,51%

P/VP

5,60

ABBV - AbbVie

US$ 208,36 9,31% (12 M)

P/L

79,66

3,38%

ROE

286,94%

P/VP

228,58

Common Questions

What is the price of Novo Nordisk (NVO) today?

The price of Novo Nordisk (NVO) today is R$ 300,50, with a variation of -57.97% compared to the last year. The price of Novo Nordisk (NVO) started the year trading around R$ 467,09 and today it is at R$ 300,50. Follow the real-time price chart, the historical price of Novo Nordisk (NVO), and stock data from Ibovespa and international markets.

When does Novo Nordisk (NVO) pay dividends?

Novo Nordisk (NVO) distributed dividends in the last year,in the months of April e August totaling R$ 6,39. The Dividend Yield for the last 12 months is 2,83%.

Novo Nordisk (NVO) is it worth it?

Currently, Novo Nordisk (NVO) is priced at R$ 300,50, with a P/E of 15,51%, representing a deviation of 29,44% from its historical average P/E. In the last year, the stock showed a variation of -57.97% in its price and distributed R$ 6,39 in dividends, resulting in a Dividend Yield of 2,83%. The total shareholder return was -57,97%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy shares of Novo Nordisk (NVO)?

Investing in shares of Novo Nordisk (NVO) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 shares of Novo Nordisk (NVO) yield today?

The yield of Novo Nordisk (NVO) was -21,95% in the last month, -57,97% in the last year and 82,21% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of R$ 9,14 in dividends, um Dividend Yield de 2,83%.

If you wanted to buy 100 shares of Novo Nordisk (NVO) today, the total investment would be based on the current price of R$ 300,50.

If past performance were to repeat, the return on your investment would be:

In 1 year: R$ 12.629,86
In 5 years: R$ 54.753,41
In 10 years: 72.410,57

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

NVO

Novo Nordisk A/S

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

profitability of NVO

check out the fundamentals of Novo Nordisk shares

P/L

P/SALES (PSR)

P/VP

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

Net Margin

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSETS

VPA

LPA

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years a year ago, today you would have

Current DY: 2,83%

5-year average DY: 1,39%

type

date with

payment date

value

ABOUT THE COMPANY Novo Nordisk

Novo Nordisk A/S

Estados Unidos

94 years

1981

45.000

Additional Information

PROFIT X PRICE NVO

NVO results

NVO cash flow

evolution of assets - NVO

NVO balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

AZN - AstraZeneca

ABBV - AbbVie

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

AZN - AstraZeneca

ABBV - AbbVie

Common Questions

Tudo que o investidor precisa em um só lugar

Pague 2, Leve 3

Anual

Valor total R$ 238,80